EUVIMEDEUVIMED entdecken
CrossrefInfokarte

V‐A ECMO as a Bridge to Heart Transplantation: Impact of Changes in Management on Failure to Rescue and Long‐Term Outcomes

Alessandra Francica, Francesco Onorati, Antonio Loforte, Cristiano Amarelli, Luca Botta, Guido Maria Olivieri, Irene Maffei, Lucrezia Palmieri, Antonio Spitaleri, Filippo Marani, Maria Elisabetta Zanolin, Claudio Russo, Marisa De Feo, Davide Pacini, Mauro Rinaldi, Giovanni Battista Luciani

Artificial Organs · 2026-11 · 50 (11) · 1616-1625

DOI: 10.1111/aor.70206 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background In the last decades, veno‐arterial extracorporeal membrane oxygenation (V‐A ECMO) has been increasingly used as a bridge to heart transplantation (HTx). This study investigates temporal trends in V‐A ECMO management for HTx and explores its impact on early and long‐term outcomes, including the concept of Failure to Rescue (FTR) from major complications. Methods A multicentre retrospective study was conducted on patients bridged to HTx using V‐A ECMO from 2003 to 2024 across five cardiac surgery Units. The primary endpoints included the evolution of V‐A ECMO management and differences in early and long‐term mortality. FTR was assessed as an indicator of postoperative care. Results A total of 137 patients were included and divided into two time‐period groups: first decade (2003–2013, n = 43) and second decade (2014–2024, n = 94). Peripheral V‐A ECMO implantation was more frequent in the second decade compared with the first decade (37.8% vs. 61.1%; p = 0.013), as well as the use of a limb reperfusion (12.2% vs. 60.4%; p = 0.001). Microaxial‐flow pump adoption as left ventricle unloading significantly increased in the second decade (2.7% vs. 25.8%, p = 0.002). Early mortality was comparable between the two groups (30.2% vs. 25.5%, first vs. second decade; p = 0.611). No statistically significant temporal change was observed in FTR rates over time. Long‐term survival was 50% and 56% at 8 years in the first and second decade, respectively ( p = 0.66). Conclusions Despite improvements in VA‐ECMO patients management, which led to an increase in the number of HTx, the incidence of mortality and major complications after HTx remained unchanged after 20 years.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →